These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
928 related articles for article (PubMed ID: 25242279)
21. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells. Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880 [TBL] [Abstract][Full Text] [Related]
22. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909 [TBL] [Abstract][Full Text] [Related]
23. Protein kinase N controls a lysosomal lipid switch to facilitate nutrient signalling via mTORC1. Wallroth A; Koch PA; Marat AL; Krause E; Haucke V Nat Cell Biol; 2019 Sep; 21(9):1093-1101. PubMed ID: 31451768 [TBL] [Abstract][Full Text] [Related]
24. Regulation of mTORC2 Signaling. Fu W; Hall MN Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899613 [TBL] [Abstract][Full Text] [Related]
25. Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis. Farhan MA; Carmine-Simmen K; Lewis JD; Moore RB; Murray AG PLoS One; 2015; 10(8):e0135245. PubMed ID: 26295809 [TBL] [Abstract][Full Text] [Related]
26. Dynamic modelling of the PI3K/MTOR signalling network uncovers biphasic dependence of mTORC1 activity on the mTORC2 subunit SIN1. Ghomlaghi M; Yang G; Shin SY; James DE; Nguyen LK PLoS Comput Biol; 2021 Sep; 17(9):e1008513. PubMed ID: 34529665 [TBL] [Abstract][Full Text] [Related]
28. Regulation of mTOR Signaling: Emerging Role of Cyclic Nucleotide-Dependent Protein Kinases and Implications for Cardiometabolic Disease. Shi F; Collins S Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511253 [TBL] [Abstract][Full Text] [Related]
29. Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation. Foster KG; Acosta-Jaquez HA; Romeo Y; Ekim B; Soliman GA; Carriere A; Roux PP; Ballif BA; Fingar DC J Biol Chem; 2010 Jan; 285(1):80-94. PubMed ID: 19864431 [TBL] [Abstract][Full Text] [Related]
30. RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes. Weinberg MA Anticancer Drugs; 2016 Jul; 27(6):475-87. PubMed ID: 26918392 [TBL] [Abstract][Full Text] [Related]
31. TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Copp J; Manning G; Hunter T Cancer Res; 2009 Mar; 69(5):1821-7. PubMed ID: 19244117 [TBL] [Abstract][Full Text] [Related]
32. mTOR complex 2 mediates Akt phosphorylation that requires PKCĪµ in adult cardiac muscle cells. Moschella PC; McKillop J; Pleasant DL; Harston RK; Balasubramanian S; Kuppuswamy D Cell Signal; 2013 Sep; 25(9):1904-12. PubMed ID: 23673367 [TBL] [Abstract][Full Text] [Related]
33. PDK4 protein promotes tumorigenesis through activation of cAMP-response element-binding protein (CREB)-Ras homolog enriched in brain (RHEB)-mTORC1 signaling cascade. Liu Z; Chen X; Wang Y; Peng H; Wang Y; Jing Y; Zhang H J Biol Chem; 2014 Oct; 289(43):29739-49. PubMed ID: 25164809 [TBL] [Abstract][Full Text] [Related]
34. Nutrient regulation of the mTOR complex 1 signaling pathway. Kim SG; Buel GR; Blenis J Mol Cells; 2013 Jun; 35(6):463-73. PubMed ID: 23694989 [TBL] [Abstract][Full Text] [Related]
35. mTORC1 and mTORC2 in cancer and the tumor microenvironment. Kim LC; Cook RS; Chen J Oncogene; 2017 Apr; 36(16):2191-2201. PubMed ID: 27748764 [TBL] [Abstract][Full Text] [Related]
36. mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8. Kim SJ; DeStefano MA; Oh WJ; Wu CC; Vega-Cotto NM; Finlan M; Liu D; Su B; Jacinto E Mol Cell; 2012 Dec; 48(6):875-87. PubMed ID: 23142081 [TBL] [Abstract][Full Text] [Related]
37. FilGAP regulates tumor growth in Glioma through the regulation of mTORC1 and mTORC2. Tsutsumi K; Nohara A; Tanaka T; Murano M; Miyagaki Y; Ohta Y Sci Rep; 2023 Dec; 13(1):20956. PubMed ID: 38065968 [TBL] [Abstract][Full Text] [Related]
38. ATP-site binding inhibitor effectively targets mTORC1 and mTORC2 complexes in glioblastoma. Neil J; Shannon C; Mohan A; Laurent D; Murali R; Jhanwar-Uniyal M Int J Oncol; 2016 Mar; 48(3):1045-52. PubMed ID: 26719046 [TBL] [Abstract][Full Text] [Related]
39. Differential effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway in acute lymphoblastic leukemia. Badura S; Tesanovic T; Pfeifer H; Wystub S; Nijmeijer BA; Liebermann M; Falkenburg JH; Ruthardt M; Ottmann OG PLoS One; 2013; 8(11):e80070. PubMed ID: 24244612 [TBL] [Abstract][Full Text] [Related]
40. Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphoma. Mazan-Mamczarz K; Peroutka RJ; Steinhardt JJ; Gidoni M; Zhang Y; Lehrmann E; Landon AL; Dai B; Houng S; Muniandy PA; Efroni S; Becker KG; Gartenhaus RB Cell Commun Signal; 2015 Mar; 13():15. PubMed ID: 25849580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]